Amicus Therapeutics Inc (FOLD.OQ)
FOLD.OQ on NASDAQ Stock Exchange Global Market
Change (% chg)
Amicus Therapeutics, Inc. is a biotechnology company. The Company is engaged in the discovery, development and commercialization of a set of treatments for patients living with devastating rare and orphan diseases. Its lead product, migalastat HCl is a small molecule that can be used as a monotherapy and in combination with... (more)
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.